Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Rocic

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|August 23, 2015
Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?Petra Rocic
Current Hypertension Reports|April 7, 2019
Comparison of Cardiovascular Benefits of Bariatric Surgery and Abdominal LipectomyPetra Rocic
Vascular Pharmacology|February 21, 2012
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?Petra Rocic
Current Drug Targets|February 5, 2016
Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?Petra Rocic
American Journal of Physiology. Heart and Circulatory Physiology|October 20, 2009
Differential phosphoinositide 3-kinase signaling: implications for PTCA?Petra Rocic
Experimental Diabetes Research|July 26, 2012
The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great explorationRebecca Hutcheson, Petra Rocic
Circulation Research|October 29, 2005
NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets SmadPetra Rocic, Pamela A Lucchesi
Pharmacology & Therapeutics|July 27, 2018
20-HETE in the regulation of vascular and cardiac functionPetra Rocic, Michal Laniado Schwartzman
Plos One|April 29, 2014
A device for performing automated balloon catheter inflation ischemia studiesSilas J Leavesley, Whitley Ledkins, Petra Rocic
American Journal of Physiology. Cell Physiology|August 2, 2003
A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth musclePetra Rocic, Hanjoong Jo, Pamela A Lucchesi
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Heart and Circulatory Physiology|August 23, 2015
Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?Petra Rocic
Current Hypertension Reports|April 7, 2019
Comparison of Cardiovascular Benefits of Bariatric Surgery and Abdominal LipectomyPetra Rocic
Vascular Pharmacology|February 21, 2012
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?Petra Rocic
Current Drug Targets|February 5, 2016
Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?Petra Rocic
American Journal of Physiology. Heart and Circulatory Physiology|October 20, 2009
Differential phosphoinositide 3-kinase signaling: implications for PTCA?Petra Rocic
Experimental Diabetes Research|July 26, 2012
The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great explorationRebecca Hutcheson, Petra Rocic
Circulation Research|October 29, 2005
NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets SmadPetra Rocic, Pamela A Lucchesi
Pharmacology & Therapeutics|July 27, 2018
20-HETE in the regulation of vascular and cardiac functionPetra Rocic, Michal Laniado Schwartzman
Plos One|April 29, 2014
A device for performing automated balloon catheter inflation ischemia studiesSilas J Leavesley, Whitley Ledkins, Petra Rocic
American Journal of Physiology. Cell Physiology|August 2, 2003
A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth musclePetra Rocic, Hanjoong Jo, Pamela A Lucchesi
Pageof 6